… with advanced non-small cell lung cancer (NSCLC) without … the methods of immune evasion
employed by NSCLC which … (2) describe the mechanisms of immune evasion (3) summarize …

… by immune checkpoint blockade (ICB). In this review, we will discuss the most recent evidence
on immune … , and the contribution of immune evasion to resistance to ICB in lung cancer. …

… In this paper we describe what is currently known about the dynamic interaction between
the cancer cell and the immune system during carcinogenesis, with a particular focus on the …

… The development of effective therapeutic approaches for patients with lung cancer, the
world’s leading cause of cancer-related death, is a critical medical need. The advent of immune …

… In our preclinical models, restoration of NKG2D ligand expression restored immune … immune
evasion mechanism by SCLCs as well as a roadmap to new immune treatment strategies. …

… genomic regions, such as endogenous retroviral elements and introns, in immune-cold
subtypes. Further, we linked immune evasion with LAG-3 via STK11 mutation-dependent HNF1A …

… the immune response. These findings highlight the need to develop immune biomarkers for
… chemopreventive approaches for individuals who are at high risk of developing lung cancer. …

… This study provides novel insights into the spatial organization of the lung cancer TME in
the context of tumor immunogenicity, tumor heterogeneity, and cancer evolution. Pairing the …

… Immune evasion is required for tumor progression and is … immune response and upregulation
of immune-suppressive signals. The coexistence of EMT and adaptive immune evasion …

… Additionally, the combined effects of immune checkpoint inhibitors and circRNAs inhibitors …
against the immune evasion of lung cancer cells and to strengthen the efficacy of lung cancer …